COMPANY NEWS
1 min read
MST Access research report
MST Access has published a research report on Lumos Diagnostics Limited.
Read article
News
Featured news
COMPANY NEWS
COMPANY NEWS
2 min read
FebriDx® Commercial Traction Continues to Advance
Lumos Diagnostics has announced further progress in the U.S. commercialisation of FebriDx® across its priority top-100 urgent care target list.
Read article
COMPANY NEWS
1 min read
REPLAY | FebriDx US Launch Update
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales
Read articleAll news
COMPANY NEWS
1 min read
FebriDx® Featured in Australian Doctor
General practitioners (GPs) routinely assess conflicting symptoms of respiratory illness in their patients - and on the balance of available information and clinical judgement, often prescribe antibiotics on the spot...
Read article
COMPANY NEWS
1 min read
Video | Q2 FY25 Investor webinar
Lumos CEO Doug Ward and CFO Barrie Lambert present the Company's latest quarterly performance...
Read article
COMPANY NEWS
1 min read
Lumos Diagnostics receives CPT PLA procedure code approval for FebriDx™ in the US
Lumos has today announced that it has received approval from the Centers for Medicare and Medicaid Services...
Read article
COMPANY NEWS
1 min read
Nine News Coverage
Lumos' FebriDx® was featured on Channel 9 News during its prime time 6pm national bulletin last night...
Read article
COMPANY NEWS
1 min read
Lumos Successfully Completes Retail Entitlement Offer
Lumos Diagnostics has announced that it has successfully completed the retail component of its Entitlement Offer...
Read article
COMPANY NEWS
1 min read
Lumos and BARDA to Partner to Support FebriDx® CLIA Waiver Study and Application
Lumos has been awarded US$2,984,571 from the Biomedical Advanced Research and Development Authority (BARDA)...
Read article
COMPANY NEWS
1 min read
Lumos Awarded National Contract with MediGroup for FebriDx®
Lumos Diagnostics has been awarded placement of their novel POC test, FebriDx®...
Read article
COMPANY NEWS
1 min read
Lumos Appoints Thermo Fisher Scientific as US Distributor for FebriDx®
Lumos Diagnostics has signed an agreement with Fisher Healthcare, a part of Thermo Fisher Scientific...
Read article
COMPANY NEWS
1 min read
Lumos Successfully Completes Institutional Component of Entitlement Offer
Lumos Diagnostics has today announced that it has successfully completed the institutional component...
Read article
COMPANY NEWS
COMPANY NEWS
1 min read
Video | Q4 FY24 Investor webinar
Lumos CEO, Doug Ward, Chief Financial Officer, Barrie Lambert, and Senior VP Commercial Operations, Paul Kase...
Read article
COMPANY NEWS
2 min read
Lumos Diagnostics Quarterly Activity Statement and Cash Flow Report period ended 30 June 2024
Lumos Diagnostics has released its Quarterly Report & 4C for the period ending 30 June 2024.
Read article